Archive: First Stage Investor


Don’t Miss This Investing Opportunity

By Allison Brickell on March 22, 2018

Dear First Stage Investor, We’ve been talking about DSTLD a lot lately, but it’s for good reason. The startup has more than 60,000 customers, more than $12 million in lifetime sales and a compounded annual sales growth of 194%. It’s the only startup we’ve recommended twice… ever. As Andy said in his original recommendation, DSTLD has gone above and beyond in several important areas: sales, customer growth, cost efficiency, profit margin expansion, product line expansion and supply line…

Crypto News Roundup

By Andy Gordon on March 15, 2018

Dear First Stage Investor, Lots happening in crypto land. So let me take you on a little tour… Keeping an Eye on the Tokyo Whale From Japan comes welcome news about the “Tokyo Whale.” Never heard of such a thing, you say? But you’ve probably heard of Mt.

Investing in Our Children

By Andy Gordon on March 8, 2018

Dear First Stage Investor, Our March issue will be hitting your inbox in just a few days. It’s one of our better issues, I believe. Now, I can’t spill all the beans in advance. You’ll have a chance to catch all the details very soon. But I can tell you…

Exclusive Invitation to DSTLD Webinar

By Andy Gordon on March 1, 2018

Livestreamed to Your Computer Monday, March 5, 4:00 p.m. to 5:00 p.m. ET Click here to register. Dear First Stage Investor, It’s been a busy few months for our portfolio company DSTLD. When we checked in with co-CEOs Mark Lynn and Corey Epstein in…

Startup Portfolio Update

By Adam Sharp on February 22, 2018

We’re overdue for a startup portfolio update. So let’s go over some recent highlights. Court Innovations (CI) has made great strides in its mission to bring every courtroom online. I spoke with CEO MJ Cartwright this month and got exciting news: It’s considering doing another round of equity…

Q&A With 20/20 GeneSystems

By Andy Gordon on February 15, 2018

Today, we’re bringing you a fascinating conversation we had with Jonathan Cohen, the founder and CEO of our recently recommended company 20/20 GeneSystems. 20/20 focuses on reducing cancer mortality worldwide through early detection. It has pioneered a novel approach of continuous machine learning using large data sets…

New Recommendation: Home61

By Andy Gordon on February 8, 2018

Security type: Common stock Round size: Up to $2 million Price per share: $5.65 Valuation: $17 million Minimum investment: $5.65 Investment portal: Netcapital Note: The amount raised under the two exemptions must total at least $10,000 by April 16, 2018, at 4:00 p.m. ET.

Crypto Markets: Nearing a Bottom?

By Adam Sharp on February 6, 2018

We’re seeing a cascade of selling in crypto markets. It’s been ugly out there. But there are signs we may be nearing a bottom… and that we could be at “peak sell-off.” This correction has been broad-based and indiscriminate. Every coin I track has been affected. But for this analysis,…

News on Cryptos and Our Portfolio

By Adam Sharp on February 1, 2018

As you have certainly noticed, the crypto market is experiencing a prolonged correction. I’m not surprised by this pullback, but it’s never exactly pleasant to watch prices dip. In my experience, it is during times like these – when it feels like the market is destined to keep falling –…

Why I’m as Bullish on Cryptocurrencies as Ever

By Andy Gordon on January 16, 2018

Bitcoin prices crept down in the early hours of morning trading today. As I write this, bitcoin is hovering just above $12,000. Yesterday it peaked above $14,000. Ethereum ranged between $1,300 and $1,350 for most of the day yesterday. As I write, it has dipped 18% to around…

News Regarding Exchanges

By Adam Sharp on January 11, 2018

Dear First Stage Investor, Cryptocurrency exchanges are exploding. During the second half of 2017, nearly every major exchange experienced a record number of new user sign-ups. The result? Growing pains. Several exchanges have experienced temporary outages or even crashes during periods of high volume. With surging cryptocurrency prices,…

We Never Did Say It Would Be a Smooth Ride, Did We?

By Andy Gordon on January 4, 2018

On Sunday, December 17, 2017, bitcoin broke through the $20,000 barrier, trading at $20,035.90. It was a big deal for some investors. But for us? Not really. Don’t get us wrong. We’re big believers in bitcoin. We recommended bitcoin to our members back in August. (I hope you followed our…

I Want Your Feedback on Bitcoin

By Adam Sharp on December 14, 2017

Dear First Stage Investor, What a week! Here’s where our portfolio stands (as of December 14, 2017)… Litecoin: $280.85 Bitcoin: $16,300.00 Ethereum: $678.44 New Economy Movement: $0.51. As I write, all our positions are in the green. Since we made our initial recommendations, we’re now up… 376% on bitcoin…

New Recommendation: 20/20 GeneSystems

By Andy Gordon on December 11, 2017

Deal Details Security Type: Preferred Stock Round Size: Up to $1.07 million Price per Share: $3.26 Valuation cap: $23 million Deadline: Midnight (PT) on Thursday, December 14 Investment portal: MicroVentures Liquidation preference: Pari passu with other series of preferred stock and senior to the common…

Don’t Set Price Targets on Cryptocurrencies

By Adam Sharp on December 7, 2017

In this week’s update, I’m going to answer an important and commonly asked question… What price should I buy the First Stage Investor cryptocurrency recommendations up to? My answer? I don’t set price targets. Cryptocurrencies are too new for that, with less than 1% of the world owning any…

Hold Strong During This Week’s Volatility

By Adam Sharp on November 30, 2017

This was one crazy week in the world of cryptocurrencies. Our portfolio has been on fire over the past few weeks. But today things are selling off hard. This correction is to be expected, and I can’t emphasize enough that this is nothing to be concerned about. As I type…